460
Participants
Start Date
June 30, 2003
Primary Completion Date
May 31, 2007
Study Completion Date
November 30, 2007
Levofloxacin
Piperacillin/Tazobactam
Sanofi-Aventis, Vienna
Sanofi-Aventis, Brussels
Sanofi-Aventis, Prague
Sanofi-Aventis, Paris
Sanofi-Aventis, Berlin
Sanofi-Aventis, Athens
Sanofi-Aventis, Guatemala City
Sanofi-Aventis, Milan
Sanofi-Aventis, Beirut
Sanofi-Aventis, México
Sanofi-Aventis, Gouda
Sanofi-Aventis, Bucharest
Sanofi-Aventis, Moscow
Sanofi-Aventis, Johannesburg
Sanofi-Aventis, Barcelona
Sanofi-Aventis, Istanbul
Sanofi-Aventis, Caracas
Lead Sponsor
Sanofi
INDUSTRY